Autor/in Mesía, R Benasso, M 1 Brümmendorf, T H 1 Cupissol, D 1 De Raucourt, D 1 Delord, J P 1 Delord, J-P 1 Erfán, J 1 Gauler, T C 1 Hitt, R 1 Kawecki, A 1 Keilholz, U 1 Kienzer, H 1 Koralewski, P 1 Krauss, J 1 Peyrade, F 1 Remenar, E 1 Rivera, F 1 Rottey, S 1 Schafhausen, P 1 Vermorken, J B 1 alle zeigenListe einklappen
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part) Vermorken, J B Peyrade, F Krauss, J Mesía, R Remenar, E Gauler, T C Keilholz, U 2014 - Forschungsinformationssystem des UKE
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck. Mesía, R Rivera, F Kawecki, A Rottey, S Hitt, R Kienzer, H Cupissol, D 2010 - Forschungsinformationssystem des UKE
